Balance Sheet

Accounts Payables Accumulated Expenses Assets Capital Leases Cash & Current Investments Cash & Equivalents Common Equity Convertible Debt Curent Deferred Tax Liability Current Assets Current Deferred Revenue Current Deferred Tax Assets Current Leases Current Taxes Goodwill Goodwill & Intangibles Intangibles Inventory Liabilities and Shareholders Equity Liabilities from Discontinued Operations Long-Term Deferred Tax Long-Term Investments Minority Interest Non-Current Assets Non-Current Debt Non-Current Deferred Tax Liability Non-Current Deffered Revenue Notes Payables Operating Leases Other Accumulated Expenses Other Non-Current Assets Other Non-Current Liabilities Payables Preferred Stock Liabilities Prepaid Assets Property, Plant & Equipment (Net)Raw Materials Receivables Receivables - Net Receivables - Other Retained Earnings Shareholder's Equity Short term Debt Short-term Investments Total Current Liabilities Total Debt Total Liabilities Total Non-Current Liabilities Treasury Shares Work In Process

Daily Values

Growth Metrics

Others

Ligand Pharmaceuticals (LGND) Current Taxes: 2024

Historic Current Taxes for Ligand Pharmaceuticals (LGND) over the last 1 years, with Dec 2024 value amounting to $1.2 million.

Ligand Pharmaceuticals' Current Taxes fell 39.09% to $1.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.3 million, marking a year-over-year decrease of 39.09%. This contributed to the annual value of $1.2 million for FY2024, which is N/A change from last year.
According to the latest figures from FY2024, Ligand Pharmaceuticals' Current Taxes is $1.2 million.
In the past 5 years, Ligand Pharmaceuticals' Current Taxes registered a high of $1.2 million during FY2024, and its lowest value of $1.2 million during FY2024.
Moreover, its 1-year median value for Current Taxes was $1.2 million (2024), whereas its average is $1.2 million.